4q25 Microdeletion with Axenfeld-Rieger Syndrome and Developmental Delay

[1] P. Goldenberg, “An update on common chromosome

microdeletion and microduplication syndromes,” Pediatric

Annals, vol. 47, no. 5, pp. e198–e203, 2018.

[2] W. M. Verhoeven, J. I. Egger, L. Gofn, L. J. van Zutven, and

G. M. Mancini, “Behavioural phenotype of a patient with a de

novo 1.2 Mb chromosome 4q25 microdeletion,” European

Journal of Medical Genetics, vol. 56, no. 6, pp. 331–335, 2013.

[3] J. L. Heithaus, K. A. Twyman, and J. R. Batanian, “A rare

recurrent 4q25 proximal deletion not involving the PITX2

gene: a genomic disorder distinct from axenfeld-rieger syndrome,” Mol Syndromol, vol. 7, no. 3, pp. 138–143, 2016.

[4] H. Titheradge, F. Togneri, D. McMullan, L. Brueton, D. Lim,

and D. Williams, “Axenfeld-Rieger syndrome: further clinical

and array delineation of four unrelated patients with a 4q25

microdeletion,” American Journal of Medical Genetics, Part A,

vol. 164, no. 7, pp. 1695–1701, 2014.

[5] E. V. Semina, R. Reiter, N. J. Leysens et al., “Cloning and

characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome,”

Nature Genetics, vol. 14, no. 4, pp. 392–399, 1996.

[6] Z. Fan, S. Sun, H. Liu et al., “Novel PITX2 mutations identifed

in Axenfeld-Rieger syndrome and the pattern of PITX2related tooth agenesis,” Oral Diseases, vol. 25, no. 8,

pp. 2010–2019, 2019.

[7] Y. Yang, X. Wang, Y. Zhao, and M. Qin, “A novel 4q25

microdeletion encompassing PITX2 associated with Rieger

syndrome,” Oral Diseases, vol. 24, no. 7, pp. 1247–1254, 2018.

[8] E. Engenheiro, J. Saraiva, I. Carreira et al., “Cytogenetically

invisible microdeletions involving PITX2 in Rieger syndrome,” Clinical Genetics, vol. 72, no. 5, pp. 464–470, 2007.

[9] W. L. Alward, “Axenfeld-Rieger syndrome in the age of

molecular genetics,” American Journal of Ophthalmology,

vol. 130, no. 1, pp. 107–115, 2000.

[10] R. Riise, K. Storhaug, and K. Brøndum-Nielsen, “Rieger

syndrome is associated with PAX6 deletion,” Acta Ophthalmologica Scandinavica, vol. 79, no. 2, pp. 201–203, 2001.

[11] B. A. Amendt, E. V. Semina, and W. L. Alward, “Rieger

syndrome: a clinical, molecular, and biochemical analysis,”

Cellular and Molecular Life Sciences, vol. 57, no. 11,

pp. 1652–1666, 2000.

[12] M. B. Shields, “Axenfeld-Rieger syndrome: a theory of

mechanism and distinctions from the iridocorneal endothelial

syndrome,” Transactions of the American Ophthalmological

Society, vol. 81, pp. 736–784, 1983.

[13] M. H. Strungaru, I. Dinu, and M. A. Walter, “Genotypephenotype correlations in Axenfeld-Rieger malformation and

glaucoma patients with FOXC1 and PITX2 mutations,” Investigative Ophthalmology & Visual Science, vol. 48, no. 1,

pp. 228–237, 2007.

Case Reports in Genetics

[14] T. A. Hjalt and E. V. Semina, “Current molecular understanding of Axenfeld-Rieger syndrome,” Expert Reviews in

Molecular Medicine, vol. 7, no. 25, pp. 1–17, 2005.

[15] P. Vande Perre, C. Zazo Seco, O. Patat et al., “4q25 microdeletion encompassing PITX2: a patient presenting with tetralogy of Fallot and dental anomalies without ocular

features,” European Journal of Medical Genetics, vol. 61, no. 2,

pp. 72–78, 2018.

[16] E. M. Strehle, L. Yu, J. A. Rosenfeld et al., “Genotypephenotype analysis of 4q deletion syndrome: proposal of

a critical region,” American Journal of Medical Genetics, Part

A, vol. 158a, no. 9, pp. 2139–2151, 2012.

[17] H. V. Firth, S. M. Richards, A. P. Bevan et al., “DECIPHER:

database of chromosomal imbalance and phenotype in

humans using ensembl resources,” Te American Journal of

Human Genetics, vol. 84, no. 4, pp. 524–533, 2009.

[18] M. Lek, K. J. Karczewski, E. V. Minikel et al., “Analysis of

protein-coding genetic variation in 60,706 humans,” Nature,

vol. 536, no. 7616, pp. 285–291, 2016.

[19] L. Moreira, A. Schinzel, A. Baumer et al., “Longitudinal

observation of a patient with Rieger syndrome and interstitial

deletion 4 (q25-q31.1),” American Journal of Medical Genetics,

Part A, vol. 152a, pp. 977–981, 2010.

[20] P. J. Mohler, J. J. Schott, A. O. Gramolini et al., “Ankyrin-B

mutation causes type 4 long-QT cardiac arrhythmia and

sudden cardiac death,” Nature, vol. 421, no. 6923, pp. 634–

639, 2003.

[21] A. J. Huq, M. D. Pertile, A. M. Davis et al., “A novel

mechanism for human cardiac ankyrin-B syndrome due to

reciprocal chromosomal translocation,” Heart Lung & Circulation, vol. 26, no. 6, pp. 612–618, 2017.

[22] H. C. Sucharski, E. K. Dudley, C. B. R. Keith, M. El Refaey,

S. N. Koenig, and P. J. Mohler, “Mechanisms and alterations

of cardiac ion channels leading to disease: role of ankyrin-B in

cardiac function,” Biomolecules, vol. 10, no. 2, p. 211, 2020.

...